MyFinsight
Home
Blog
About
Available-for-sale securities, at
fair value
$1,547,201K
(100.78%↑ Y/Y)
Other current assets
$35,522K
(169.92%↑ Y/Y)
Cash, cash
equivalents and restricted...
$35,074K
Prepaid expenses
$25,373K
(7.10%↑ Y/Y)
Cash, cash
equivalents and restricted...
$19,685K
Accounts receivable
$8,556K
(-11.78%↓ Y/Y)
Gross carrying amount
$24,857K
(0.00%↑ Y/Y)
Total current assets
$1,671,411K
(76.51%↑ Y/Y)
Property, plant and
equipment, net
$373,301K
(-2.03%↓ Y/Y)
Right-of-use assets
$55,667K
(26.51%↑ Y/Y)
Other assets
$6,048K
(347.01%↑ Y/Y)
Intangible assets, net
$5,586K
(-23.33%↓ Y/Y)
Accumulated amortization
$19,271K
(9.68%↑ Y/Y)
Total assets
$2,112,013K
(52.98%↑ Y/Y)
Total liabilities,
noncontrolling interest and...
$2,112,013K
(52.98%↑ Y/Y)
Total long-term
liabilities
$1,362,626K
(104.51%↑ Y/Y)
Total noncontrolling
interest and...
$466,041K
(-10.34%↓ Y/Y)
Total current
liabilities
$283,346K
(45.66%↑ Y/Y)
Convertible notes, net
$682,707K
Liability related to the
sale of future...
$392,512K
(8.95%↑ Y/Y)
Credit facility, net of
current portion
$141,366K
(-29.43%↓ Y/Y)
Lease liabilities,
net of current...
$114,298K
(8.14%↑ Y/Y)
Deferred revenue, net of
current portion
$31,743K
Stockholders equity
$465,529K
(-10.87%↓ Y/Y)
Noncontrolling interest
$512K
(120.42%↑ Y/Y)
Deferred revenue
$94,596K
(311.66%↑ Y/Y)
Accrued expenses
$86,174K
(32.95%↑ Y/Y)
Credit facility
$40,000K
(0.00%↑ Y/Y)
Accounts payable
$27,776K
(-15.96%↓ Y/Y)
Accrued payroll and
benefits
$23,455K
(21.54%↑ Y/Y)
Other liabilities
$6,023K
(-18.33%↓ Y/Y)
Lease liabilities
$5,322K
(-24.08%↓ Y/Y)
Accumulated deficit
-$1,923,355K
(-19.95%↓ Y/Y)
Treasury stock at cost
2,661 shares of common...
$53,193K
Accumulated other
comprehensive (loss) income
-$1,234K
(-123.04%↓ Y/Y)
Additional paid-in capital
$2,443,074K
(15.23%↑ Y/Y)
Common stock, 0.001 par
value authorized...
$237K
(3.04%↑ Y/Y)
Back
Back
Balance Sheet
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
source: myfinsight.com